Tepnel Life Sciences PLC: Statement re share price movement
Manchester, U.K, 22 January 2009 The Board of Tepnel Life Sciences PLC (AIM: TED), the international Molecular Diagnostics and Research Products & Services group, notes the recent share price movement and confirms that the Company has received an approach which may or may not lead to an offer being made for the Company. The Board emphasizes that discussions are at an early stage and that there can be no assurance that an offer will be forthcoming.

